The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Healthcare & Insurance

Two-Year Feasibility Study Results Encouraging with Medtronic Harmony(TM) Transcatheter Pulmonary Valve

DUBLIN and SAN DIEGO - April 26, 2018 - Medtronic plc (NYSE: MDT) today announced two-year outcomes for the Harmony(TM) Transcatheter Pulmonary Valve (TPV) from its early feasibility study. Presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 41st Annual Scientific

Thursday, April 26, 2018

Guerbet announces the acquisition of a new microsphere technology to strengthen its interventional imaging range

  Acquisition of a technology developed by Occlugel, a French company specialized in the R&D of microspheres used in embolization; This new technology will round out Guerbet's Interventional Imaging solutions and create synergies with the Accurate range of anti-reflux microcatheters.

Thursday, April 26, 2018

SCOR's combined general meeting of April 26, 2018 adopts all the proposed resolutions

Press Release April 26, 2018 - N° 12   SCOR's combined general meeting of April 26, 2018 adopts all the proposed resolutions The Combined General Meeting of SCOR SE was held on April 26, 2018 in Paris and was chaired by Mr. Denis Kessler, Chairman and Chief Executive

Thursday, April 26, 2018

PotNetwork Holdings, Inc. Posts Record First Quarter Revenues of $6.3 Million; Strong and Steady Momentum Bolsters Sales Performance 283% Over First

FT. LAUDERDALE, Fla., April 26, 2018 (GLOBE NEWSWIRE) --  -- Via OTC PR Wire --  PotNetwork Holdings, Inc. (OTC Pink:POTN) On Thursday the 26th of April in 2018, PotNetwork Holdings, Inc. announced record breaking Q1 revenues totaling $6.3 Million. Compared with $1,858,347 in revenues for Q1

Thursday, April 26, 2018

Construction Begins on Colombian Cannabis Cultivation Greenhouse

VANCOUVER, British Columbia, April 26, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (“ICC Labs” or the “Company”) (TSX-V:ICC) (Frankfurt:2Q9) is pleased to announce that it has started building a 124,000 sq. ft. greenhouse in Tabio, Cundinamarca, close to Bogotá, where the Company intends to

Thursday, April 26, 2018

Loop Industries Appoints Nelson Switzer as Chief Growth Officer

MONTREAL, April 26, 2018 (GLOBE NEWSWIRE) -- Loop™ Industries, Inc. (NASDAQ:LOOP) today announced that it has appointed Nelson Switzer as Chief Growth Officer to lead the commercialization of Loop’s disruptive sustainability technology and build the Loop brand in the marketplace. He will

Thursday, April 26, 2018

Tauriga Biz Dev. Corp. Enters into Reseller Agreement with Blink Charging Company; Agreement Presents the Company with Potential Long-Term Recurring

NEW YORK, NY, April 26, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities

Thursday, April 26, 2018

Aquinox to Present at 2018 Bloom Burton & Co. Healthcare Conference

VANCOUVER, British Columbia, April 26, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat inflammation, inflammatory pain, and blood cancers, announced today that

Thursday, April 26, 2018

Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2018

SALT LAKE CITY, April 26, 2018 (GLOBE NEWSWIRE) -- In the first calendar quarter (1Q) of 2018, Utah Medical Products, Inc. (Nasdaq:UTMD) attained results consistent with achieving its financial goals for year 2018.  Summary of results.The following is a summary comparison of 1Q 2018 with 1Q

Thursday, April 26, 2018

Alphatec to Report First Quarter 2018 Financial Results on May 10, 2018

CARLSBAD, Calif., April 26, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“Alphatec” or the “Company”) (Nasdaq:ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through the relentless pursuit of superior outcomes, announced today that the

Thursday, April 26, 2018

Knalysis Technologies is a KIRA Award Finalist!

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, April 26, 2018 (GLOBE NEWSWIRE) -- Knalysis Technologies (“Knalysis”), a subsidiary of Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) is thrilled to announce

Thursday, April 26, 2018

BioCorRx CEO Brady Granier and Actor Jeremy Miller Appear on Varney & Co. on Fox Business to Discuss the Company's Sustained Release Naltrexone

ANAHEIM, CA, April 26, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that Brady Granier, BioCorRx CEO, President, and Director, as well as actor Jeremy

Thursday, April 26, 2018

Minerva Neurosciences to Report First Quarter 2018 Financial Results and Business Updates on May 3, 2018

Management to host conference call WALTHAM, Mass., April 26, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that it will

Thursday, April 26, 2018

Yield10 Addresses Application of Metabolic Engineering to Increase Crop Yield in Paper Published in Plant Science

Chief Science Officer Kristi Snell also confirmed as a keynote speaker at upcoming plant meeting  WOBURN, Mass., April 26, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN), a Company developing new technologies to create step-change improvements in crop yield to enhance global

Thursday, April 26, 2018

Emisphere Amends License Agreement with Novo Nordisk

Emisphere to Receive $7 Million Payment ROSELAND, N.J., April 26, 2018 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) today announced that it has amended its existing 2015 Development and License Agreement with Novo Nordisk A/S (NYSE:NVO) for the development and

Thursday, April 26, 2018

Progenics Pharmaceuticals Sets First Quarter 2018 Financial Results Call for May 9

NEW YORK, April 26, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative medicines and imaging analytical tools for targeting and treating cancer, announced today that it will host a conference call and webcast to review the first

Thursday, April 26, 2018

Corvus Pharmaceuticals Announces Initiation of Phase 1/1b Clinical Trial of Investigational Anti-CD73 Antibody, CPI-006, in Patients with Advanced

Three-arm Trial Will Evaluate CPI-006 as Monotherapy, in Combination with CPI-444 Adenosine Antagonist and in Combination with Pembrolizumab BURLINGAME, Calif., April 26, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company focused on

Thursday, April 26, 2018

Agritek Holdings, Inc. Announces Purchase And Transfer Of Tier One Recreational License For Colorado On Behalf Of Approved Partner Licensee With

Company Expands Operations In Colorado On Heel Of New Deal With President Trump And Senator Cory Gardner Clearing Way For Colorado Medical And Recreational Cannabis LOS ANGELES, CA, April 26, 2018 (GLOBE NEWSWIRE) -- Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com, a fully

Thursday, April 26, 2018

William Hartman, CEO of Premier Biomedical, Returns to Uptick Newswire’s “Stock Day” Podcast

PHOENIX, April 26, 2018 (GLOBE NEWSWIRE) -- William Hartman, CEO of Premier Biomedical Inc. (OTCBB:BIEI) ("the Company") joined Everett Jolly on Uptick Newswire’s “Stock Day” podcast to discuss recent company developments. Premier Biomedical consists of two groups: The Biologics Group

Thursday, April 26, 2018

Imagin Gains Momentum; Positive Progress in Research Study

VANCOUVER, British Columbia and BOSTON, April 26, 2018 (GLOBE NEWSWIRE) -- Imagin Medical (CSE:IME) (OTC PINK:IMEXF) (Frankfurt & Stuttgart Symbol:DPD2) (the “Company”) is providing the following update on the Company’s current activities. The recent closing of a Private Placement for

Thursday, April 26, 2018

loading

© 2018 Stock News Now